TFRC and Parkinson disease: Quantification based on the immunoblots revealed a significant reduction of both TF and TFRC protein levels in the AD cortices (p = 0.0010 and <0.0001 respectively) but only reduction of TFRC in PD (p < 0.001) patients compared to CN individuals (Figures 7A, B).